Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial
Erin F. Gillespie, Joanna C. Yang, Noah J. Mathis, Catherine B. Marine, Charlie White, Zhigang Zhang, Christopher A. Barker, Rupesh Kotecha, Alyson McIntosh, Max Vaynrub, Meredith Bartelstein, Aaron Philip Mitchell, David Guttmann, Divya Yerramilli, Daniel S. Higginson, Yoshida J. Yamada, Zachary A. Kohutek, Simon N. Powell, Jillian Tsai, Jonathan T. Yang
Abstract
PURPOSE: External-beam radiation therapy (RT) is standard of care (SOC) for pain relief of symptomatic bone metastases. We aimed to evaluate the efficacy of radiation to asymptomatic bone metastases in preventing skeletal-related events (SRE). METHODS: In a multicenter randomized controlled trial, adult patients with widely metastatic solid tumor malignancies were stratified by histology and planned SOC (systemic therapy or observation) and randomly assigned in a 1:1 ratio to receive RT to asymptomatic high-risk bone metastases or SOC alone. The primary outcome of the trial was SRE. Secondary outcomes included hospitalizations for SRE and overall survival (OS). RESULTS: = .01). CONCLUSION: Radiation delivered prophylactically to asymptomatic, high-risk bone metastases reduced SRE and hospitalizations. We also observed an improvement in OS with prophylactic radiation, although a confirmatory phase III trial is warranted.